Haghighat, Maryam
Browning, Lisa
Sirinukunwattana, Korsuk
Malacrino, Stefano
Khalid Alham, Nasullah
Colling, Richard
Cui, Ying
Rakha, Emad
Hamdy, Freddie C.
Verrill, Clare
Rittscher, Jens
Funding for this research was provided by:
Innovate UK (104689 / Application number: 18181)
NIHR Oxford Biomedical Research Centre
Article History
Received: 24 September 2021
Accepted: 3 March 2022
First Online: 23 March 2022
Competing interests
: JR and KS are co-founders of Ground Truth Labs. PathLAKE has received in kind industry investment from Philips. University of Oxford, Oxford University Hospitals NHS Foundation Trust and University of Nottingham are part of the PathLAKE consortium. CV is the principal investigator of a study evaluating Paige Prostate. This work was done when MH was with University of Oxford, Oxford, UK. Other authors do not have competing interest.